Scale up HIV treatment for children: The right tools, right now!

Thursday 21 July, 18:30-20:30, Session Room 5. 

Satellite Session

The Drugs for Neglected Diseases initiative (DNDi), the Clinton Health Access Initiative (CHAI), UNITAID, and the National Empowerment Network of People living with HIV/AIDS in Kenya (NEPHAK) will be sharing practical and programmatic experience – including both successes and challenges – developing and introducing new paediatric ARV formulations.

AIDS 2016 - Paediatric HIV Satellite Event

This Satellite Session will explore how to ensure that when optimal formulations are developed, they are rapidly adopted and introduced so that large-scale treatment of infants and young children with HIV can be implemented and sustained. The Satellite will bring in perspectives from WHO and affected communities as well as from country implementers, product developers, donor agencies, and non-governmental organizations.

For more information download the event flyer [PDF, 4 MB]


Moving Self-Testing from a Theory to a Reality for Africa

Wednesday 20 July, 18:30-20:30. Session Room 4.


Owen Mugurungi, Ministry of Health-Zimbabwe

Rachel Baggaley, World Health Organization

Rosanna Peeling

Increased uptake of HIV testing is crucial to reaching the United Nation's (UN) 90-90-90 goal. HIV self-testing (HIVST) could play an important role in increasing uptake and frequency of testing, while ensuring linkage into care.



UNITAID strives to find new ways to prevent, diagnose and treat HIV more quickly and effectively. UNITAID’s involvement at the International AIDS Conference in 2016 in Durban, South Africa will showcase its work to promote innovations in testing, treatment and monitoring of HIV with a range of partners including UNICEF, Population Services International, USAID, The Global Fund, Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the Drugs for Neglected Diseases initiative.


UNITAID & EGPAF Innovation Satellite

Innovations needed to support Treatment for All: From incremental to game-changing
Tuesday, 19 July 2016, 18h30-20h30

Treatment for all is now recommended by the WHO guidelines. The individual and public health benefits are indisputable, and yet despite progress in scaling up antiretroviral therapy, 21.2 million people living with HIV are still in need of treatment. We believe that by focusing on the use and scale up of innovative tools, the combined efforts of the HIV community - from affected populations to Ministries of Health and donors – will meet treatment needs and achieve global targets.


UNITAID at 10: Innovation in Global Health

The role of UNITAID and why it matters


Deaths from HIV/AIDS, TB and malaria have halved from 6 million in 2000.

This turnaround was no accident. It was spurred by visionary political leadership, galvanising a big increase in funding over two decades and a surge of innovation that have brought about a dramatic increase in availability of effective new treatments.